Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.07.2019 | short review

Skin tumours in organ transplant recipients—implications for the plastic surgeon

verfasst von: Johanna Krapf, M.D., Gerhard Pierer, M.D.

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Summary

Squamous cell carcinoma of the skin (SCC) and basal cell carcinoma (BCC) are common entities, often with a benign course. Tumour biology, however, is different in immunosuppressed individuals, such as organ transplant recipients (OTR). As immunosuppression-sparing protocols have not yet been successfully introduced to the clinics, nonmelanoma skin cancers (NMSCs) will continue to affect a majority of OTR, leading to significant morbidity and mortality. Interdisciplinary treatment including the transplant physician, dermatologist and the plastic surgeon is warranted for optimal patient management. This review focuses on special tumour characteristics and therapeutic requirements among OTR. Recommendations for local treatment and oncoplastic surgery are discussed.
Vorheriger Artikel Immunosuppression after renal transplantation
Nächster Artikel Risk of cancer after long-term therapy of autoimmune disorders with glucocorticoids or DMARDs—a controversial issue
Literatur
1.
Kim R, Armstrong A. Non-melanoma skin cancer. Dermatol Clin. 2012;30:125–39.CrossRef
2.
Mittal A, Colegio O. Skin cancers in organ transplant recipients. Am J Transpl. 2017;17:2509–30.CrossRef
3.
Greenberg J, Zwald F. Management of skin cancer in solid organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29:231–41.CrossRef
4.
Thompson A, Kelley B, Prokop L, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. Jama Dermatol. 2016;152:419–28.CrossRef
5.
Brantsch K, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20.CrossRef
6.
Acuna S, Fernandes K, Daly C, et al. Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. Jama Oncol. 2016;2(4):463–9.CrossRef
7.
Terhorst D, Drecoll U, Stockfleth E, et al. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol. 2009;161(Suppl. 3):85–9.CrossRef
8.
O’Donovan P, Perret C, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871–4.CrossRef
9.
Ulrich C, Jurgensen J, Degen A, et al. Prevention of nonmelanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24-month, prospective, case–control study. Br J Dermatol. 2009;161(Suppl. 3):78–84.CrossRef
10.
Reichrath J, Nurnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14.CrossRef
11.
Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39.CrossRef
12.
Chen A, Martin A, Choy B, et al. A phase 3 randomized trial of Nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26.CrossRef
13.
Drago F, Ciccarese G, Cogorno L, et al. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol. 2017;27:382–5.PubMed
14.
Veness M, Palme C, Morgan G. High-risk squamous cell carcinoma of the head and neck. Results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;23:2389–96.CrossRef
15.
Padhya T, Cornelius R, Athavale S, et al. Perineural extension to the skull base from early cutaneous malignancies of the midface. Otolaryngol Head Neck Surg. 2007;137:742–6.CrossRef
16.
Leibovitch I, Huilgol S, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6.CrossRef
17.
Nahhas A, Scarbrough C, Trotter S, et al. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10(4):37–46.PubMedPubMedCentral
18.
19.
Sterry W, European Dermatology Forum Guideline Committee. Guidelines: The management of basal cell carcinoma. Eur J Dermatol. 2006;16(5):467–75.
20.
Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel lymph node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75–9.CrossRef
21.
Ward D, London N, Collar R. Role of secondary intention healing. Facial Plast Surg. 2013;29(05):346–50.CrossRef
22.
Roine E, Bjork I, Oyen O, et al. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc. 2010;42(7):2542–6.CrossRef
23.
Veness M, Porceddu S, Palme C, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31.CrossRef
Metadaten
Titel
Skin tumours in organ transplant recipients—implications for the plastic surgeon
verfasst von
Johanna Krapf, M.D.
Gerhard Pierer, M.D.
Publikationsdatum
01.07.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0504-7

Weitere Artikel der Ausgabe 3/2019

News from ASH 2018—how can we afford innovation in the future?

  • editorial

Screening and prophylaxis of cancer

  • editorial

CML at the 2018 ASH meeting—selected presentations

  • short review

Cutaneous melanoma—The benefit of screening and preventive measures

  • short review

HIV-triggered lymphoma

  • short review

Post San Antonio Breast Cancer Symposium 2018